Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 102, Issue 3, 2010, Pages 209-214

  Seo, Young Seok ^a   Kim, Mi Sook ^a   Yoo, Sung Yul ^a   Cho, Chul Koo ^a   Choi, Chul Won ^a   Kim, Jin Ho ^a   Han, Chul Ju ^b   Park, Su Cheol ^b   Lee, Byung Hee ^b   Kim, Young Han ^b   Lee, Dong Han ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

CyberKnife; Hepatocellular carcinoma; Stereotactic radiotherapy

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; MUSCULOSKELETAL DISEASE; OVERALL SURVIVAL; PARALYTIC ILEUS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION INJURY; SALVAGE THERAPY; SOFT TISSUE INJURY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOSURGERY; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 77956358143     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21593     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Nakamura H, Mitani T, Murakami T, et al.: Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33:S89-S92. (Pubitemid 24147973)
3. Seong J, Keum KC, Han KH, et al.: Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1999;43:393-397. (Pubitemid 29091482)
4. Robertson JM, Lawrence TS, Dworzanin LM, et al.: Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286-1293. (Pubitemid 23199131)
5. Cheng SH, Lin YM, Chuang VP, et al.: A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 1999;14:1025-1033. (Pubitemid 29487300)
6. Shim SJ, Seong J, Han KH, et al.: Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int 2005;25:1189-1196. (Pubitemid 41782564)
7. Park W, Lim DH, Paik SW, et al.: Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005;61:1143-1150. (Pubitemid 40340909)
8. Shirato H, Seppenwoolde Y, Kitamura K, et al.: Intrafractional tumor motion: Lung and liver. Semin Radiat Oncol 2004;14:10-18. (Pubitemid 38168950)
9. Gunderson LL, Haddock MG, Foo ML, et al.: Conformal irradiation for hepatobiliary malignancies. Ann Oncol 1999;10:221-225.
10. Bruix J, Sherman M, Llovet JM, et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
11. Kim JG, Lee DH, Kim MS: A study of the reduction of organ motion from respiration. Korea J Med Phys 2004;15:179-186.
12. Kim MS, Ha SH, Lee DH, et al.: Distortion of the dose profile in a three-dimensional moving phantom to simulate tumor motion during image-guided radiosurgery. J Korean Soc Ther Radiol Oncol 2007;25:268-277.
13. Schefter TE, Kavanagh BD, Timmerman RD, et al.: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62:1371-1378. (Pubitemid 40982057)
14. Therasse P, Arbuck SG, Eisenhauer EA, et al.: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
15. Trotti A, Colevas AD, Setser A, et al.: CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181. (Pubitemid 36962641)
16. Lawrence TS, Robertson JM, Anscher MS, et al.: Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31:1237-1248.
17. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
18. Rosenblum ML, Knebel KD, Vasquez DA, et al.: In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Cancer Res 1976;36:3718-3725.
19. Kim JJ, Tannock IF: Repopulation of cancer cells during therapy: An important cause of treatment failure. Nat Rev Cancer 2005;5:516-525.
20. Seong J, Park HC, Han KH, et al.: Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000;47:1331-1335. (Pubitemid 30421186)
21. Wu DH, Liu L, Chen LH: Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2004;10:2184-2189. (Pubitemid 39144964)
22. Guo WJ, Yu EX, Liu LM, et al.: Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 2003;9:1697-1701. (Pubitemid 37038115)
23. Taguchi H, Sakuhara Y, Hige S, et al.: Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalities. Int J Radiat Oncol Biol Phys 2007;69:376-380. (Pubitemid 47380097)
24. Tse RV, Hawkins M, Lockwood G, et al.: Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008;26:657-664. (Pubitemid 351264363)
25. Seong J, Park HC, Han KH, et al.: Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003;55:329-336. (Pubitemid 36069090)
26. Park HC, Seong J, Han KH, et al.: Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002;54:150-155.
27. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al.: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677-682.
28. Rusthoven KE, Kavanagh BD, Cardenes H, et al.: Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-1578.
29. Dunlap NE, Cai J, Biedermann GB, et al.: Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:796-801.